A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
This study is ongoing, but not recruiting participants.
Astellas Pharma Global Development, Inc.
First Posted: July 26, 2012
Last Update Posted: September 21, 2017
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Global Development, Inc. )